is ozempic a tirzepatide or semaglutide & are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from What Are Tirzepatide and Semaglutide

Are the injections difficult to administer

For patients requiring even greater weight reductions, tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist now available in India, has demonstrated up to 20.9% body weight reduction in the SURMOUNT-1 trial, surpassing both semaglutide and dulaglutide

Dotson and calibrated to your labs, not a standard dose

Excess weight, particularly around the abdomen, can increase intra-abdominal pressure, which may in turn affect the function of the upper and lower esophageal sphincters

They share common gastrointestinal side effects including nausea, diarrhea, constipation, and vomiting